CMV pneumonitis primary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

CMV pneumonitis Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating CMV pneumonitis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Criteria
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
CMV pneumonitis primary prevention On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of CMV pneumonitis primary prevention All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on CMV pneumonitis primary prevention
CDC on CMV pneumonitis primary prevention
CMV pneumonitis primary prevention in the news
Blogs on CMV pneumonitis primary prevention
Directions to Hospitals Treating CMV pneumonitis
Risk calculators and risk factors for CMV pneumonitis primary prevention

Primary Prevention

The following have been shown to help prevent CMV pneumonia in certain patients:

• Using organ transplant donors who don't have CMV.
• Using CMV-negative blood products for transfusion.
• Using CMV-immune globulin in certain patients.
• Preventing AIDS avoids opportunistic diseases, including CMV, that can occur in people who have a damaged or poorly functioning immune system. People with AIDS who have a CD4 count of less than 100 should consider taking preventive treatment for CMV.